|
Amarin Corp Plcuk (NASDAQ: AMRN) |
|
Amarin Corp Plcuk
AMRN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Amarin Plcuk's sales fell
by -25.66 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 3088
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.43 %
Amarin Plcuk net loss increased from $-10 millions, to $-16 millions in first quarter of 2025,
• More on AMRN's Growth
|
|
Amarin Plcuk realized a net loss in trailing twelve months.
Amarin Plcuk realized cash reduction of $ -4.58 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.21.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on AMRN's Valuation
|
|
|
|
|
Amarin Plcuk realized net loss in trailing twelve months.
Amarin Plcuk realized cash outflow of $ -4.58per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.21.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
Amarin Plcuk Price to Book Ratio is at 0.55 lower than Industry Avg. of 33.79. and higher than S&P 500 Avg. of 0.01
• More on AMRN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com